Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe/Simvastatin vs Doubling Statin Dose in CAD
NCT00166530Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Nov 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ezetimibe in coronary artery disease (CAD), atherosclerosis, hypercholesterolemia, sponsored by Organon & Co.. Started Nov 2005; status: completed.
02
Drugs
ezetimibe
03
Conditions
coronary artery disease (CAD)atherosclerosishypercholesterolemia
Beyond the preview
Go deeper on NCT00166530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00166530.